Evidence map›Paper›PMID 36356582›Full record

ArticleCell2022

An ancestral mycobacterial effector promotes dissemination of infection.

Joseph W Saelens, Mollie I Sweeney, Gopinath Viswanathan, Ana María Xet-Mull, Kristen L Jurcic Smith, Dana M Sisk, Daniel D Hu, Rachel M Cronin, Erika J Hughes, W Jared Brewer and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Gene conversion is a key driver of diversity hotspots inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. PDIM/PGL-deficientMicrobiology resource announcements · 2026
    Article
  6. Host- and pathogen-related determinants of pulmonaryEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  7. Whole Genome Sequencing of ClinicalInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. ESX-5 Deletions inbioRxiv : the preprint server for biology · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Journal of bacteriology · 2025
    Review
  14. Article
  15. Review
  16. Experimental dissection of tuberculosis protective immunity: a human perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  17. Article
  18. Tuberculosis prevention: current strategies and future directions.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Joseph W SaelensDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Mollie I SweeneyDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Gopinath ViswanathanDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Ana María Xet-MullDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Kristen L Jurcic SmithDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Dana M SiskDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Daniel D HuDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
Rachel M CroninDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.
Erika J HughesDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
W Jared BrewerDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Jörn CoersDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.
Matthew M ChampionDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA.
Patricia A ChampionDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA.
Craig B LoweDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Clare M SmithDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Sunhee LeeDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: sunhlee@utmb.edu.
Jason E StoutDepartment of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: jason.stout@duke.edu.
David M TobinDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: david.tobin@duke.edu.
Duke University · USUniversity of Notre Dame · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Macrophage Reprogramming During Granuloma Formation in the ZebrafishR01AI130236 · NIAID · DUKE UNIVERSITY · PI David M. Tobin · 2017 to 2026
$4.5M
Genetic dissection of angiogenesis in the tuberculous granulomaR01AI125517 · NIAID · DUKE UNIVERSITY · PI David M. Tobin · 2017 to 2026
$4.4M
IRGM-driven host responses to Chlamydia trachomatis infectionsR01AI103197 · NIAID · DUKE UNIVERSITY · PI COERS, JOERN · 2013 to 2023
$4.2M
Role of N-alpha acetylation in mycobacterial secretion and virulenceR01AI106872 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2013 to 2024
$4.2M
Interferon-inducible cell-autonomous immunity to cytosolic bacterial pathogensR01AI139425 · NIAID · DUKE UNIVERSITY · PI Jorn Coers · 2019 to 2026
$3.4M
The Genetic Basis of Bone Disease in Mycobacterial InfectionR01AI127715 · NIAID · DUKE UNIVERSITY · PI Clare Margaret Smith, David M. Tobin · 2017 to 2026
$3.3M
Interferon-inducible cell-intrinsic host defense against Chlamydia trachomatisR37AI103197 · NIAID · DUKE UNIVERSITY · PI Jorn Coers · 2024 to 2026
$1.6M
Dissecting the genetic basis of protective immunity to tuberculosis in diverse hostsDP2GM146458 · NIGMS · DUKE UNIVERSITY · PI SMITH, CLARE MARGARET · 2021 to 2021
$1.4M
The Genetic Basis of Bone Disease in Mycobacterial InfectionR21AI111067 · NIAID · DUKE UNIVERSITY · PI LEE, SUNHEE, STOUT, JASON E · 2015 to 2016
$434k
Exploration of the genetic interaction between secreted virulence determinants from pathogenic mycobacteriaR21AI142127 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2019 to 2020
$425k
The requirement for PDIM in mycobacterial protein secretionR03AI149147 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHAMPION, PATRICIA A · 2020 to 2021
$156k
NHLBI NIH HHS F31 HL163994NIAID NIH HHS R01 AI106872NIAID NIH HHS R01 AI125517NIAID NIH HHS R01 AI127715NIAID NIH HHS R01 AI130236NIAID NIH HHS R01 AI139425NIAID NIH HHS R03 AI149147NIAID NIH HHS R21 AI111067NIAID NIH HHS R21 AI142127NIAID NIH HHS R37 AI103197NIAID NIH HHS UC6 AI058607NIGMS NIH HHS DP2 GM146458
6 · The paper itself

Abstract

The human pathogen Mycobacterium tuberculosis typically causes lung disease but can also disseminate to other tissues. We identified a M. tuberculosis (Mtb) outbreak presenting with unusually high rates of extrapulmonary dissemination and bone disease. We found that the causal strain carried an ancestral full-length version of the type VII-secreted effector EsxM rather than the truncated version present in other modern Mtb lineages. The ancestral EsxM variant exacerbated dissemination through enhancement of macrophage motility, increased egress of macrophages from established granulomas, and alterations in macrophage actin dynamics. Reconstitution of the ancestral version of EsxM in an attenuated modern strain of Mtb altered the migratory mode of infected macrophages, enhancing their motility. In a zebrafish model, full-length EsxM promoted bone disease. The presence of a derived nonsense variant in EsxM throughout the major Mtb lineages 2, 3, and 4 is consistent with a role for EsxM in regulating the extent of dissemination.

Indexed as

Bone DiseasesMycobacterium marinumMycobacterium tuberculosisTuberculosisAnimalsBacterial ProteinsHumansMacrophagesZebrafishBacterial ProteinsdisseminationESX-5EsxMevolutionmacrophageMycobacterium marinumMycobacterium tuberculosistuberculosistype VII secretion

Identifiers

PMID36356582
PMCPMC9691622
OpenAlexW4308658038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.